Skip to content

ICU Medical ICUI EBITDA margin

EBITDA margin at other companies

Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
7%-0.6pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
20.2%+0.9pp
Baxter International logo
Baxter InternationalBAX
5.9%-6.2pp
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
22.1%+0.3pp
TFX
TeleflexTFX
13.6%-10.6pp
Moog logo
MoogMOG.A

Other financials

Income statement

See full
Revenue$530.2M-12.3%
Gross profit$206.2M-1.8%
Operating income$13.6M+5.4%
Net income$30.1M+295%
EPS (diluted)$1.20+290%

Balance sheet

See full
Cash & equivalents$288.3M-0.5%
Total debt$1.4B-17.5%
Total equity$2.1B+6.3%
Total assets$4.0B-4.1%

Cash flow

See full
Operating cash flow$38.9M-24.2%
CapEx$11.3M-22.7%
Free cash flow$27.6M-24.8%

Valuation

See full
Market cap$3.51B-6.3%
Enterprise value$4.58B-10.6%
P/E75.3×+70.9×
P/S1.6×+0.1×

Profitability

See full
Gross margin37.9%+2.8pp
Operating margin2%-0.7pp
Net margin-0.3%-0.2pp
FCF margin4.2%-1.2pp

Returns & leverage

See full
Return on equity-0.4%-0.2pp
Debt / equity0.6×-0.2×
Current ratio2.3×-0.3×

Where this comes from

Calculated from ICU Medical’s reported figures.

Based on trailing twelve months.

The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ICU Medical's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ICU Medical's EBITDA margin?
ICU Medical (ICUI) reported EBITDA margin of 11.4% in Q1 2026.
How has ICU Medical's EBITDA margin changed year-over-year?
ICU Medical's EBITDA margin decreased by 1.9% year-over-year, from 11.6% to 11.4%.
What is the long-term trend for ICU Medical's EBITDA margin?
Over 5 years (2020 to 2025), ICU Medical's EBITDA margin has grown at a -5.5% compound annual growth rate (CAGR), from 14.5% to 10.9%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.